H.C. Wainwright Maintains Collplant(CLGN.US) With Buy Rating, Maintains Target Price $11

Futu NewsNov 29 23:32 · Ratings

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 28 05:05

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 28 00:42 · Conference Call

D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $14 Price Target

BenzingaNov 27 21:47 · Ratings

CollPlant Biotechnologies Analyst Ratings

BenzingaNov 27 21:45 · Ratings

Collplant Biotechnologies' Cash And Cash Equivalents As Of September 30, 2024 Were $15.4M, Expected To Provide Cash Runway Until The End Of 2025

BenzingaNov 27 20:06